X
Maggie's Pearl
Log in
Sign up
Maggie's Pearl
105 posts
Maggie's Pearl
@epalrestat
Clinical-stage biotech company developing epalrestat as the first targeted therapy for PMM2-CDG and other Congenital Disorders of Glycosylation
Sturgis, MI
maggiespearl.com
Joined January 2021
144
Following
405
Followers
Posts
Posts
Replies
Replies
Media
Media
Don't miss what's happening
People on X are the first to know.
Log in
Sign up
@epalrestat hasn’t posted
When they do, their posts will show up here.
×
Advertisement
